Mark Knudson, PhD
Dr. Knudson is Founder, Chairman, President and Chief Executive Officer of EnteroMedics Inc (NASDAQ:ETRM), a position he has held since 2003. He has previously served as Managing Partner of an early stage venture capital firm and as President of Johnson and Johnson Professional Diagnostics, a Johnson and Johnson Company, following Johnson and Johnson's (NYSE:JNJ) acquisition of Arden Medical Systems, a company he founded in 1983. Subsequently, Dr. Knudson was the founder or involved in the founding of over 20 healthcare companies and successfully exited via acquisitions or initial public offerings (IPO). He held positions in Research and Development management at Cardiac Pacemakers, Inc. (CPI-Guidant) and was a member of the faculty of the University of Washington School of Medicine in Seattle, Washington. He was the recipient of an Individual Post-doctoral Fellowship Award from the National Institutes of Health. Dr. Knudson received a PhD (physiology) from Washington State University and a BS in biology from Pacific Lutheran University. He holds numerous United States patents. He serves or has served on boards of several companies and institutions, both public and private. Dr. Knudson was elected to membership in Sigma Xi, the scientific research society of North America in 1975 and is a Fellow of the American Heart Association.